cimetidine has been researched along with nizatidine in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (16.05) | 18.7374 |
1990's | 40 (49.38) | 18.2507 |
2000's | 18 (22.22) | 29.6817 |
2010's | 10 (12.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Biagini, GA; Chandramohanadas, R; Darling, C; DeGrado, WF; Diamond, SL; Fisher, N; Greenbaum, DC; Jing, H; Jo, H; Lucumi, E; Napper, AD; Shone, AE; Ward, SA | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blago, MR; Girmania, P; Laguzzi, E; Sitar, G | 1 |
Elezoglou, A; Kounenis, G; Koutsoviti-Papadopoulou, M; Voutsas, A | 1 |
Bachmann, K; Jauregui, L; Levine, L; Martin, M; Mauro, LS; Sullivan, TJ | 1 |
Michocki, RJ; Richardson, JP | 1 |
Chia, SC; Chong, YY; Fock, KM; Yap, CK | 1 |
Fox, MJ; Frank, WO; Nambi, P; Palmer, RH; Wetherington, JD | 1 |
Baraona, E; Caballería, J; Deulofeu, R; Hernández-Muñoz, R; Lieber, CS; Rodés, J | 1 |
Nwokolo, CU; Pounder, RE; Sawyerr, AM; Smith, JT | 1 |
Guram, M; Holt, S; Howden, CW | 1 |
Kurimoto, T; Omata, T; Ozeki, M; Segawa, Y; Tagashira, E; Takei, M; Tsuzuike, N; Yamaji, Y | 1 |
Abe, T; Aita, H; Chaki, K; Kurimoto, T; Morita, H; Omata, T; Segawa, Y; Ueki, S; Yamaji, Y; Yoshida, A | 1 |
Enriz, RD; Jáuregui, EA | 1 |
Best, KL; Goode, RL; Hirsch, KS; Lin, TM; Neubauer, BL; Pioch, RP; Probst, KS; Shaar, CJ; Tinsley, FC | 1 |
Fagan, TC; Fennerty, B; Lipsy, RJ | 1 |
Gavey, C; Nwokolo, CU; Pounder, RE; Sawyerr, A; Smith, JT | 1 |
Cherner, JA; Cloud, ML; Latz, JE; Offen, WW | 1 |
Dammann, HG; Dreyer, M; Gottlieb, WR; Müller, P; Simon, B; Wolf, N | 1 |
Chapman, JM; Kosh, JW; Sowell, JW | 1 |
Gardner, JD; Jensen, RT; Maton, PN | 1 |
Evans, DC; Lin, TM; Pioch, RP; Warrick, MW | 1 |
Arvela, P; Klotz, U; Pasanen, M; Pelkonen, O; Sotaniemi, E | 1 |
Dammann, HG; Dreyer, M; Gottlieb, WR; Keohane, P; Müller, P; Simon, B; Walter, TA | 1 |
Gavaler, JS; Heyl, A; Susen, B; Van Thiel, DH | 1 |
Hammond, JB; Offen, WW | 1 |
Matsumoto, C; McMahon, FG; Offen, WW; Regel, G; Ryan, J; Vargas, R | 1 |
Dicke, JM; Henderson, GI; Johnson, RF; Kuehl, TJ; Schenker, S | 1 |
Forsyth, DR; Jayasinghe, KS; Roberts, CJ | 1 |
Harada, M; Kaneko, H; Kotera, H; Mitsuma, T; Nagai, H; Uchida, K | 1 |
Castell, DO; Just, RJ; Lagerström, PO; Leite, LP | 1 |
Bosron, WF; Davis, GJ; Hurley, TD; Kedishvili, NY; Li, TK; Peggs, CF; Stone, CL; Thomasson, HR | 1 |
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ | 1 |
Aoki, T; Fukuda, S; Hanyu, N; Hashimoto, Y; Iikura, M; Ohira, Y | 1 |
Howden, CW; Kelman, AW; McGill, PE; Milligan, PA; Whiting, B | 1 |
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, JH; Sullivan, TJ | 1 |
Nakamura, H; Sano, H; Sugiyama, Y; Yamazaki, M | 1 |
Gugler, R | 1 |
Ring, BJ; Wrighton, SA | 1 |
Aita, H; Chaki, K; Hori, Y; Itoh, Z; Morita, H; Seiki, M; Tagashira, E; Ueki, S; Yoneta, T | 1 |
Notar-Francesco, V; Raffaniello, RD; Raufman, JP; Straus, EW | 1 |
Kriegler, A; van der Walt, BJ; van Zyl, JM | 1 |
Jacyna, MR; Levi, AJ; Miller, RJ; O'Reilly, S; Ross, J; Ryder, SD | 1 |
Iga, T; Kawakami, J; Sawada, Y; Shimokawa, M; Yamamoto, K | 1 |
Csepregi, A; Nemesánszky, E | 1 |
Berstad, A; Hatlebakk, JG | 1 |
Iga, T; Matsuo, H; Sawada, Y; Takedomi, S; Yamamoto, K; Yamano, K | 1 |
Chase, SL; Peterson, AM; Wordell, CJ | 1 |
Aster, RH; Curtis, BR; Gentilini, G | 1 |
Berlin, JA; Burnham, D; Weinberg, DS | 1 |
Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH | 1 |
Chang, BL; Ho, C; Hsu, SY; Huang, HM; Shaw, CY | 1 |
Itoh, Z; Matsunaga, Y; Tamaki, H; Ueki, S; Yoneta, T | 1 |
Davis, SS; He, P; Illum, L | 1 |
Etchason, J; Fultz, SL; Good, CB; Trilli, L | 1 |
Furuta, S; Kamada, E; Kawabata, Y; Sano, H; Shinozaki, Y; Sugimoto, T; Suzuki, T | 1 |
Chen, SH; Ho, YH; Ko, HS; Wu, HL; Wu, SM | 2 |
Basit, AW; Lacey, LF; Newton, JM | 1 |
Sanders, TA; Taylor, D; Werneke, U | 1 |
Itoh, H; Naito, T; Takeyama, M | 1 |
Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
Darwish, IA; Hassan, AI; Hussein, SA; Mahmoud, AM | 1 |
Ashiru, DA; Basit, AW; Patel, R | 1 |
Chang, YX; Du, LM; Guo, M; Li, CF; Qiu, YQ | 1 |
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
Ouyang, D; Wan, J; Wang, R; Yin, H; Zheng, Y | 1 |
Diogo, HP; Moura Ramos, JJ; Viciosa, MT | 1 |
10 review(s) available for cimetidine and nizatidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The clinical use of histamine-2 receptor antagonists.
Topics: Cimetidine; Drug Evaluation; Famotidine; Gastroesophageal Reflux; Humans; Nizatidine; Peptic Ulcer; Ranitidine; Recurrence; Time Factors | 1992 |
Clinical review of histamine2 receptor antagonists.
Topics: Cimetidine; Drug Interactions; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Nizatidine; Ranitidine; Stomach Ulcer; Thiazoles | 1990 |
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome | 1989 |
H2-antagonists and alcohol. Do they interact?
Topics: Alcohol Dehydrogenase; Animals; Cimetidine; Drug Interactions; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Nizatidine; Ranitidine; Rats | 1994 |
[H2-receptor antagonists and alcohol: clinical significance].
Topics: Cimetidine; Clinical Medicine; Drug Interactions; Ethanol; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Humans; Liver; Nizatidine; Piperidines; Ranitidine | 1996 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Effect of histamine-2 receptor antagonists on blood alcohol levels: a meta-analysis.
Topics: Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Nizatidine; Ranitidine | 1998 |
Options for pharmacological management of obesity in patients treated with atypical antipsychotics.
Topics: Amantadine; Antipsychotic Agents; Cimetidine; Cyclobutanes; Fluoxetine; Fructose; Humans; Lactones; Metformin; Nizatidine; Obesity; Orlistat; Topiramate; Weight Gain | 2002 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
14 trial(s) available for cimetidine and nizatidine
Article | Year |
---|---|
Role of H2-receptor antagonists in the treatment of duodenitis.
Topics: Cimetidine; Duodenitis; Female; Histamine H2 Antagonists; Humans; Male; Nizatidine; Ranitidine | 1992 |
Nizatidine versus cimetidine in the treatment of duodenal ulcers.
Topics: Adult; Aged; Cimetidine; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Thiazoles; Wound Healing | 1991 |
Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Topics: Adult; Cimetidine; Drug Administration Schedule; Drug Tolerance; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Humans; Male; Nizatidine; Ranitidine; Stomach | 1991 |
Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Cimetidine; Creatinine; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nizatidine; Patient Compliance; Random Allocation; Smoking; Thiazoles | 1989 |
[Inhibition of 24-hour acidity by nizatidine].
Topics: Cimetidine; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Famotidine; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Nizatidine; Random Allocation; Ranitidine; Thiazoles | 1989 |
Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Topics: Adult; Cimetidine; Drug Evaluation; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Nizatidine; Random Allocation; Ranitidine; Thiazoles; Time Factors | 1986 |
An evaluation of the anti-androgen effects associated with H2 antagonist therapy.
Topics: Adolescent; Adult; Cimetidine; Histamine H2 Antagonists; Humans; Hypothalamo-Hypophyseal System; Male; Nizatidine; Pituitary Hormones, Anterior; Sperm Count; Testis; Testosterone; Thiazoles; Thyroxine | 1987 |
Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Topics: Adult; Aged; Betazole; Body Water; Cimetidine; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastric Juice; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nizatidine; Pepsin A; Pyrazoles; Random Allocation; Thiazoles | 1988 |
Pharmacokinetics and pharmacodynamics of oral nizatidine.
Topics: Administration, Oral; Adult; Cimetidine; Dietary Proteins; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Nizatidine; Thiazoles; Time Factors | 1988 |
Do nizatidine and cimetidine interact with ibuprofen?
Topics: Adult; Cimetidine; Double-Blind Method; Drug Interactions; Half-Life; Histamine H2 Antagonists; Humans; Ibuprofen; Male; Nizatidine; Thiazoles | 1988 |
The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disorders.
Topics: Adult; Aged; Aged, 80 and over; Arthritis; Cimetidine; Drug Interactions; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Peptic Ulcer; Piroxicam | 1993 |
Short report: a comparative study of the interaction between antacid and H2-receptor antagonists.
Topics: Adult; Antacids; Biological Availability; Chromatography, High Pressure Liquid; Cimetidine; Dose-Response Relationship, Drug; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine | 1994 |
Histamine-2 receptor antagonists do not alter serum ethanol levels in fed, nonalcoholic men.
Topics: Adult; Asian People; Cimetidine; Drug Interactions; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Prospective Studies; Ranitidine | 1993 |
Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Topics: Adult; Calcitonin Gene-Related Peptide; Cimetidine; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Ranitidine; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2002 |
57 other study(ies) available for cimetidine and nizatidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Topics: Animals; Antimalarials; Drug Resistance, Multiple; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Topics: Acetylcholine; Animals; Cimetidine; Colon, Sigmoid; Famotidine; Female; Gastric Fundus; Histamine H2 Antagonists; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nizatidine; Rabbits; Ranitidine | 1992 |
Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients.
Topics: Administration, Oral; Aged; Cimetidine; Delayed-Action Preparations; Humans; Lung Diseases, Obstructive; Middle Aged; Nizatidine; Ranitidine; Theophylline | 1992 |
Effects of various concomitant medications on gastric alcohol dehydrogenase and the first-pass metabolism of ethanol.
Topics: Acetaminophen; Adult; Alcohol Dehydrogenase; Animals; Cimetidine; Ethacrynic Acid; Ethanol; Female; Histamine H2 Antagonists; Humans; In Vitro Techniques; Male; Middle Aged; Nizatidine; Propranolol; Ranitidine; Rats; Reference Values; Salicylates; Salicylic Acid | 1991 |
Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Topics: Alcohol Dehydrogenase; Animals; Cimetidine; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Liver; Male; Nizatidine; Ranitidine; Rats; Rats, Inbred Strains | 1991 |
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine | 1991 |
Effects of the new anti-ulcer drug nizatidine on prostaglandins in the rat gastric mucosa.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cimetidine; Dinoprostone; Dose-Response Relationship, Drug; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; In Vitro Techniques; Male; Microsomes; Nizatidine; Prostaglandins; Ranitidine; Rats; Rats, Inbred Strains; Sheep | 1991 |
Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Topics: Animals; Cimetidine; Gastric Acid; Gastrins; Male; Nizatidine; Pylorus; Ranitidine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1991 |
[Theoretical conformation study of tiotidine and nizatidine, two strong histamine H2-receptor antagonists].
Topics: Cimetidine; Isomerism; Models, Theoretical; Molecular Conformation; Nizatidine; Receptors, Histamine H2 | 1991 |
Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
Topics: Androgens; Animals; Cimetidine; Gastric Acid; Histamine H2 Antagonists; Hypothalamus; Male; Metribolone; Molecular Structure; Nizatidine; Orchiectomy; Organ Size; Pituitary Gland; Preoptic Area; Prolactin; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen; Seminal Vesicles; Testis; Thiazoles | 1990 |
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Topics: Adult; Cimetidine; Drug Tolerance; Famotidine; Gastric Acid; Gastrins; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Nizatidine; Ranitidine | 1990 |
A comparison of the cholinergic activity of selected H2-antagonists and sulfoxide metabolites.
Topics: Acetylcholine; Animals; Brain Chemistry; Cholinesterase Inhibitors; Cimetidine; Famotidine; Furans; Histamine H2 Antagonists; Ileum; Male; Mice; Nizatidine; Parasympathomimetics; Ranitidine; Structure-Activity Relationship; Sulfoxides; Thiazoles | 1989 |
Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs.
Topics: Administration, Oral; Animals; Cimetidine; Dogs; Dose-Response Relationship, Drug; Gastric Acid; Histamine H2 Antagonists; Infusions, Parenteral; Molecular Weight; Nizatidine; Rana catesbeiana; Rats; Tetragastrin; Thiazoles | 1986 |
Effect of five structurally diverse H2-receptor antagonists on drug metabolism.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cimetidine; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Diazepam; Famotidine; Histamine H2 Antagonists; Humans; Imidazoles; Kinetics; Male; Microsomes, Liver; Nizatidine; Oxidoreductases; Oxygenases; Pharmaceutical Preparations; Ranitidine; Rats; Rats, Inbred Strains; Thiazoles | 1986 |
A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta.
Topics: Adolescent; Adult; Animals; Antipyrine; Biological Transport; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Nizatidine; Papio; Perfusion; Placenta; Pregnancy; Ranitidine; Thiazoles | 1988 |
New H2-blockers: does more choice help?
Topics: Anti-Ulcer Agents; Cimetidine; Famotidine; Humans; Nizatidine; Peptic Ulcer; Ranitidine; Thiazoles | 1988 |
Nizatidine accelerates gastric emptying of a solid meal in rats.
Topics: Acetylcholine; Animals; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Gastric Emptying; Gastric Juice; Gastrins; Histamine H2 Antagonists; Male; Nizatidine; Rats; Rats, Wistar; Stimulation, Chemical | 1995 |
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole | 1995 |
Cimetidine inhibition of human gastric and liver alcohol dehydrogenase isoenzymes: identification of inhibitor complexes by kinetics and molecular modeling.
Topics: Alcohol Dehydrogenase; Binding, Competitive; Cimetidine; Famotidine; Gastric Mucosa; Humans; Isoenzymes; Kinetics; Liver; Mathematics; Models, Molecular; NAD; Nizatidine; Ranitidine; Recombinant Proteins; Structure-Activity Relationship | 1995 |
Drug interactions of H2-receptor antagonists.
Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline | 1994 |
[Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
Topics: Animals; Cimetidine; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Emptying; Gastrointestinal Motility; Histamine H2 Antagonists; Nizatidine; Piperidines; Ranitidine | 1993 |
Carrier-mediated active transport of histamine H2 receptor antagonists, cimetidine and nizatidine, into isolated rat hepatocytes: contribution of type I system.
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Cimetidine; Dose-Response Relationship, Drug; Histamine H2 Antagonists; Hydrogen-Ion Concentration; In Vitro Techniques; Liver; Male; Metabolic Clearance Rate; Nizatidine; Rats; Rats, Sprague-Dawley | 1994 |
Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.
Topics: Chromatography, High Pressure Liquid; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Midazolam; Nifedipine; Nizatidine | 1994 |
Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
Topics: Animals; Cholinesterase Inhibitors; Cimetidine; Digestive System; Digestive System Physiological Phenomena; Dogs; Dose-Response Relationship, Drug; Famotidine; Fasting; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Histamine H2 Antagonists; Humans; Male; Motor Activity; Nizatidine; Pylorus; Rats; Rats, Sprague-Dawley | 1993 |
Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
Topics: Antioxidants; Cimetidine; Famotidine; Ferrous Compounds; Histamine H2 Antagonists; Hydrogen Peroxide; Hydroxides; Hydroxyl Radical; Hypochlorous Acid; Iron Chelating Agents; NAD; Nizatidine; Peroxidase; Ranitidine | 1993 |
Long term acid suppressing treatment in general practice.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Cimetidine; Drug Utilization; Duodenal Ulcer; England; Esophageal Diseases; Family Practice; Famotidine; Female; Gastric Acid; Humans; Long-Term Care; Male; Middle Aged; Nizatidine; Patient Satisfaction; Ranitidine | 1994 |
Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
Topics: Animals; Anticonvulsants; Brain; Cimetidine; Convulsants; Famotidine; GABA Agonists; Histamine H2 Antagonists; Injections, Intraventricular; Male; Mice; Models, Biological; Nizatidine; Ranitidine; Receptors, Histamine H2; Seizures | 1996 |
Quantitative prediction of the interaction of midazolam and histamine H2 receptor antagonists in rats.
Topics: Animals; Area Under Curve; Cimetidine; Drug Interactions; Half-Life; Histamine H2 Antagonists; Liver; Male; Metabolic Clearance Rate; Midazolam; Models, Biological; Nizatidine; Rats; Rats, Wistar | 1998 |
Therapeutic-interchange program for oral histamine H2-receptor antagonists.
Topics: Cimetidine; Drug Utilization; Histamine H2 Antagonists; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Nizatidine; Pennsylvania; Pharmacy Service, Hospital | 1998 |
An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug-induced antibodies.
Topics: Aged; Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Blood Platelets; CHO Cells; Cimetidine; Cricetinae; Cricetulus; Epitopes; Famotidine; Female; Flow Cytometry; Histamine H2 Antagonists; Humans; Molecular Structure; Nizatidine; Platelet Glycoprotein GPIb-IX Complex; Precipitin Tests; Protein Conformation; Quinidine; Quinine; Ranitidine; Recombinant Fusion Proteins; Structure-Activity Relationship; Thrombocytopenia; Transfection | 1998 |
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine | 1998 |
Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products.
Topics: Algorithms; Chromatography, High Pressure Liquid; Cimetidine; Famotidine; Histamine H2 Antagonists; Nizatidine; Ranitidine; Regression Analysis; Reproducibility of Results; Solvents; Spectrophotometry, Ultraviolet | 1999 |
Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Cisapride; Digestion; Dogs; Duodenum; Famotidine; Gastric Emptying; Gastrointestinal Motility; Injections, Intravenous; Intubation, Gastrointestinal; Male; Nizatidine; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Stomach | 1999 |
Chitosan microspheres prepared by spray drying.
Topics: Biocompatible Materials; Biopolymers; Calorimetry, Differential Scanning; Chitin; Chitosan; Cimetidine; Cross-Linking Reagents; Delayed-Action Preparations; Famotidine; Histamine H2 Antagonists; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Nizatidine; Particle Size; Viscosity | 1999 |
Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization.
Topics: Aged; Cimetidine; Cost Savings; Drug Costs; Duodenal Ulcer; Formularies, Hospital as Topic; Gastroesophageal Reflux; Health Services Research; Histamine H2 Antagonists; Hospitals, Veterans; Humans; Male; Middle Aged; Nizatidine; Outpatient Clinics, Hospital; Pennsylvania; Retrospective Studies; Stomach Ulcer; Therapeutic Equivalency | 2000 |
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.
Topics: Anti-Ulcer Agents; Cimetidine; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Male; Microsomes, Liver; Nizatidine; Omeprazole; Pharmaceutical Preparations | 2001 |
Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.
Topics: Buffers; Cimetidine; Electric Conductivity; Electrophoresis, Capillary; Ethylene Glycol; Famotidine; Histamine H2 Antagonists; Humans; Nizatidine; Phosphates; Ranitidine; Sensitivity and Specificity; Time Factors; Water | 2001 |
Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
Topics: Anti-Ulcer Agents; Buffers; Calibration; Cimetidine; Famotidine; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Molecular Structure; Nizatidine; Phosphates; Ranitidine; Tablets; Time Factors | 2001 |
Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora.
Topics: Bacteria, Anaerobic; Cimetidine; Digestive System; Famotidine; Female; Histamine H2 Antagonists; Humans; Nizatidine | 2002 |
Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV).
Topics: Aminobenzoates; Cerium; Cimetidine; Dosage Forms; Excipients; Famotidine; Histamine H2 Antagonists; Nizatidine; Oxidation-Reduction; Ranitidine; Reproducibility of Results; Solvents; Spectrophotometry; Time Factors | 2008 |
Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
Topics: Chromatography, High Pressure Liquid; Cimetidine; Famotidine; Histamine H2 Antagonists; Humans; Nizatidine; Ranitidine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2007 |
Determination of ranitidine, nizatidine, and cimetidine by a sensitive fluorescent probe.
Topics: Bridged-Ring Compounds; Cimetidine; Fluorescent Dyes; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Imidazoles; Nizatidine; Ranitidine; Spectrometry, Fluorescence; Temperature | 2011 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |
Molecular Encapsulation of Histamine H₂-Receptor Antagonists by Cucurbit[7]Uril: An Experimental and Computational Study.
Topics: Bridged-Ring Compounds; Cimetidine; Famotidine; Histamine H2 Antagonists; Imidazoles; Molecular Dynamics Simulation; Nizatidine | 2016 |
The Slow Relaxation Dynamics in the Amorphous Pharmaceutical Drugs Cimetidine, Nizatidine, and Famotidine.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cimetidine; Famotidine; Nizatidine; Time Factors | 2016 |